The stock shed 5.60% to $2.19 in after-hours trading. Supernus Pharmaceuticals Inc (NASDAQ: SUPN)’s second-quarter revenues climbed 5.2% year-over-year to $104.7 million. The earnings per share missed …
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout
Leave a reply